{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T07:18:17Z","timestamp":1778397497620,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HR22C141104"],"award-info":[{"award-number":["HR22C141104"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.neurot.2024.e00463","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T04:54:12Z","timestamp":1728622452000},"page":"e00463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Therapeutic effects of mirodenafil, a phosphodiesterase 5 inhibitor, on stroke models in rats"],"prefix":"10.1016","volume":"22","author":[{"given":"Fred","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Padmanabh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunji","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyang","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Keun","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sae Kwang","family":"Ku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jai Jun","family":"Choung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2024.e00463_bib1","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa1804492","article-title":"Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016","volume":"379","author":"GlroS","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.neurot.2024.e00463_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14634","article-title":"Advancing stroke therapy: a deep dive into early phase of ischemic stroke and recanalization","volume":"30","author":"He","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.neurot.2024.e00463_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neuroscience.2024.02.017","article-title":"New perspectives in neuroprotection for ischemic stroke","volume":"550","author":"P\u00e9rez-Mato","year":"2024","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurot.2024.e00463_bib4","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/ana.1249","article-title":"A\u00a0nitric oxide donor induces neurogenesis and reduces functional deficits after stroke in rats","volume":"50","author":"Zhang","year":"2001","journal-title":"Ann Neurol: Official Journal of the American Neurological Association and the Child Neurology Society"},{"key":"10.1016\/j.neurot.2024.e00463_bib5","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1161\/01.RES.0000056757.93432.8C","article-title":"Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the rat","volume":"92","author":"Zhang","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.neurot.2024.e00463_bib6","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1517\/13543784.2013.793672","article-title":"Targeting nitric oxide in the subacute restorative treatment of ischemic stroke","volume":"22","author":"Zhang","year":"2013","journal-title":"Expet Opin Invest Drugs"},{"key":"10.1016\/j.neurot.2024.e00463_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111128","article-title":"Phosphodiesterase 5 (PDE5): structure-function regulation and therapeutic applications of inhibitors","volume":"134","author":"Ahmed","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.neurot.2024.e00463_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/940207","article-title":"Phosphodiesterase-5 inhibitors: action on the signaling pathways of neuroinflammation, neurodegeneration, and cognition","volume":"2015","author":"Peixoto","year":"2015","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.neurot.2024.e00463_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113818","article-title":"Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer's disease","volume":"176","author":"Zuccarello","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neurot.2024.e00463_bib10","first-page":"1351","article-title":"Sildenafil improves vascular and metabolic function in patients with Alzheimer's disease","volume":"60","author":"Sheng","year":"2017","journal-title":"J\u00a0Alzheim Dis"},{"key":"10.1016\/j.neurot.2024.e00463_bib11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5534\/wjmh.2014.32.1.18","article-title":"Mirodenafil for\u00a0the\u00a0treatment of erectile dysfunction: a systematic review of the literature","volume":"32","author":"Park","year":"2014","journal-title":"World J Mens Health"},{"key":"10.1016\/j.neurot.2024.e00463_bib12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13195-022-01034-3","article-title":"Phosphodiesterase 5 inhibitor mirodenafil ameliorates Alzheimer-like pathology and symptoms by multimodal actions","volume":"14","author":"Kang","year":"2022","journal-title":"Alzheimer's Res Ther"},{"key":"10.1016\/j.neurot.2024.e00463_bib13","first-page":"1","article-title":"The potential therapeutic effect of phosphodiesterase 5 inhibitors in the acute ischemic stroke (AIS)","author":"AlRuwaili","year":"2023","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.neurot.2024.e00463_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cellsig.2017.06.015","article-title":"Phosphodiesterase 5 inhibition as a therapeutic target for ischemic stroke: a systematic review of preclinical studies","volume":"38","author":"\u00d6lmestig","year":"2017","journal-title":"Cell Signal"},{"key":"10.1016\/j.neurot.2024.e00463_bib15","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.3390\/cells10102766","article-title":"Sildenafil-mediated neuroprotection from adult to neonatal brain injury: evidence, mechanisms, and future translation","volume":"10","author":"Zinni","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.neurot.2024.e00463_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01097-6","article-title":"Sildenafil improves hippocampal brain injuries and restores neuronal development after neonatal hypoxia\u2013ischemia in male rat pups","volume":"11","author":"Yazdani","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurot.2024.e00463_bib17","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1161\/01.STR.0000034399.95249.59","article-title":"Sildenafil (Viagra) induces neurogenesis and promotes functional recovery after stroke in rats","volume":"33","author":"Zhang","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.neurot.2024.e00463_bib18","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/01.STR.0000158923.19956.73","article-title":"Functional recovery in aged and young rats after embolic stroke: treatment with a phosphodiesterase type 5 inhibitor","volume":"36","author":"Zhang","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.neurot.2024.e00463_bib19","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1124\/jpet.109.156919","article-title":"Phosphodiesterase 5A inhibitors improve functional recovery after stroke in rats: optimized dosing regimen with implications for mechanism","volume":"331","author":"Menniti","year":"2009","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"key":"10.1016\/j.neurot.2024.e00463_bib20","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.brainres.2006.08.028","article-title":"Tadalafil, a long-acting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke","volume":"1118","author":"Zhang","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.neurot.2024.e00463_bib21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.expneurol.2014.07.007","article-title":"Yonkenafil: a novel phosphodiesterase type 5 inhibitor induces neuronal network potentiation by a cGMP-dependent Nogo-R axis in acute experimental stroke","volume":"261","author":"Chen","year":"2014","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neurot.2024.e00463_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0165-6147(97)01157-7","article-title":"To what extent have functional studies of ischaemia in animals been useful in the assessment of potential neuroprotective agents?","volume":"19","author":"Hunter","year":"1998","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neurot.2024.e00463_bib23","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.STR.20.1.84","article-title":"Reversible middle cerebral artery occlusion without craniectomy in rats","volume":"20","author":"Longa","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.neurot.2024.e00463_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/jcbfm.1981.6","article-title":"Description of technique and early neuropathological consequences following middle cerebral artery occlusion","volume":"1","author":"Tamura","year":"1981","journal-title":"J\u00a0Cerebr Blood Flow Metabol"},{"key":"10.1016\/j.neurot.2024.e00463_bib25","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1161\/01.STR.20.10.1383","article-title":"Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats","volume":"20","author":"De Ryck","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.neurot.2024.e00463_bib26","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1523\/JNEUROSCI.15-07-05372.1995","article-title":"Elevated body swing test: a new behavioral parameter for rats with 6-hydroxydopamine-induced hemiparkinsonism","volume":"15","author":"Borlongan","year":"1995","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.neurot.2024.e00463_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","article-title":"Developments of a water-maze procedure for studying spatial learning in the rat","volume":"11","author":"Morris","year":"1984","journal-title":"J\u00a0Neurosci Methods"},{"key":"10.1016\/j.neurot.2024.e00463_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-016-0560-4","article-title":"Sildenafil, a cyclic GMP phosphodiesterase inhibitor, induces microglial modulation after focal ischemia in the neonatal mouse brain","volume":"13","author":"Moretti","year":"2016","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.neurot.2024.e00463_bib29","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3340\/jkns.2021.0101","article-title":"Phosphodiesterase-5 inhibitor attenuates anxious phenotypes and movement disorder induced by mild ischemic stroke in rats","volume":"65","author":"Yu","year":"2022","journal-title":"Journal of Korean Neurosurgical Society"},{"key":"10.1016\/j.neurot.2024.e00463_bib30","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/jnr.20813","article-title":"Delayed treatment with sildenafil enhances neurogenesis and improves functional recovery in aged rats after focal cerebral ischemia","volume":"83","author":"Zhang","year":"2006","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1016\/j.neurot.2024.e00463_bib31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.brainres.2006.10.098","article-title":"Angiogenesis and improved cerebral blood flow in the ischemic boundary area detected by MRI after administration of sildenafil to rats with embolic stroke","volume":"1132","author":"Li","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.neurot.2024.e00463_bib32","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.pbb.2008.10.009","article-title":"Tadalafil improves short-term memory by suppressing ischemia-induced apoptosis of hippocampal neuronal cells in gerbils","volume":"91","author":"Ko","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neurot.2024.e00463_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.914537","article-title":"Activation of Wnt\/beta-catenin signaling pathway as a promising therapeutic candidate for cerebral ischemia\/reperfusion injury","volume":"13","author":"Mo","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.neurot.2024.e00463_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1287857","article-title":"Mechanisms of immune response and cell death in ischemic stroke and their regulation by natural compounds","volume":"14","author":"Gong","year":"2024","journal-title":"Front Immunol"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747924001508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747924001508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:24:39Z","timestamp":1740140679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747924001508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1878747924001508"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00463","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic effects of mirodenafil, a phosphodiesterase 5 inhibitor, on stroke models in rats","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00463","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00463"}}